Overdose deaths continued to rise in San Francisco in the
first six months of 2019, mostly due to rises in fentanyl and methamphetamine overdoses,
according to data released by the San Francisco Department of Public Health.
Through June 30, the Department of Public Health recorded
182 confirmed overdose deaths, continuing a rising trend from 259 overdose
deaths in all of 2018 and 222 in 2017. The agency released the data set on
Tuesday.
Deaths attributed to the ultra-potent opioid fentanyl
totaled 69 in the first half of 2019, according to the SFDPH. Fentanyl
overdoses doubled from 11 in 2015 to 22 in 2016, followed by increases to 36
deaths in 2017 and 89 in 2018.
Public health officials first began to notice fentanyl laced
in other street drugs in the city, but the drug has become a go-to choice for some
people in recent years. The synthetic opioid is up to 100 times more potent
than morphine, according to the Centers for Disease Control and Prevention.
“Unfortunately, since the second half of 2018, we —
like every community that has seen fentanyl take over the street opioid market
— have faced rising mortality due to fentanyl,” said Department of Public
Health Director of Substance Research Dr. Phillip Coffin.
Public health officials confirmed 112 methamphetamine
overdose deaths in the first half of last year, on pace to dwarf 2018’s 126
overdose deaths and 2017’s 99 deaths.
The agency also noted that partial data from 2019’s second
half indicated a “substantial increase” in both fentanyl and
methamphetamine overdose deaths.
To combat the rise of overdose deaths, particularly for
opioids like fentanyl, the Department of Public Health has sought to make
medications like naloxone, also known as Narcan, and buprenorphine more widely
available to people dealing with an addiction.
San Francisco’s Drug Overdose Prevention and Education
Project recorded nearly 1,800 overdose reversals by using naloxone from January
to September 2019.
Public health officials have also reached out to homeless residents
battling addiction by offering buprenorphine prescriptions to people who may
not be able to access traditional methods of health care.
“For people who are not ready to stop using entirely,
we find that buprenorphine also treats the risk of opioid overdose,” said
Dr. Barry Zevin, the medical director of the Department of Public Health’s Street
Medicine team. “We have not had overdoses among patients who continue to
use buprenorphine. Lowering barriers to addiction treatment saves lives.”
The Department of Public Health offers naloxone, fentanyl
test strips and other harm reduction supplies at no cost at the CBHS Pharmacy
at 1380 Howard St., Glide Harm Reduction Services at 330 Ellis St. and the
Sixth Street Harm Reduction Center at 117 Sixth St.
The city also offers an online bed-finder tool at FindTreatmentSF.org
for residents seeking treatment for addiction withdrawal, residential treatment
programs and living spaces for people undergoing outpatient care.
Source: NBC Bay Area
Be First to Comment